Harrow, Inc. Accounts Payable and Accrued Liabilities
Harrow, Inc. (HROW) had Accounts Payable and Accrued Liabilities of $41.41 million as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2025-03-27
- 2024-12-31: Accounts Payable and Accrued Liabilities $41.41M.
- 2024-09-30: Accounts Payable and Accrued Liabilities $27.99M.
- 2024-06-30: Accounts Payable and Accrued Liabilities $24.98M.
- 2024-03-31: Accounts Payable and Accrued Liabilities $17.84M.
| Period end | Accounts Payable and Accrued Liabilities | Accounts Payable and Accrued Liabilities as first filed |
|---|---|---|
| 2024-12-31 | $41.41M 10-K · filed 2025-03-27 | |
| 2024-09-30 | $27.99M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $24.98M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $17.84M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $24.58M 10-K · filed 2025-03-27 | $27.29M 10-K · filed 2024-03-19 |
| 2023-09-30 | $15.48M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $20.10M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $16.07M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $13.77M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $14.11M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $9.20M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $6.76M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $6.34M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $7.33M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $5.21M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $5.98M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $4.73M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $6.49M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $6.58M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $8.33M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $8.50M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $8.94M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $7.74M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $6.94M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $7.05M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $6.73M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $5.46M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $4.68M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $4.68M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $4.83M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $4.01M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $4.59M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.21M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $4.38M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.46M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $4.75M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $3.91M 10-K · filed 2017-03-21 | |
| 2015-09-30 | $2.43M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.70M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $1.18M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $817.00K 10-K · filed 2016-03-23 | $816.33K 10-K · filed 2015-03-12 |
| 2014-09-30 | $842.36K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $750.11K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $457.11K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $311.92K 10-K · filed 2015-03-12 | |
| 2013-09-30 | $725.50K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $868.37K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $700.79K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $691.17K 10-K · filed 2014-03-28 | $635.38K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |